Karen Lu honored by AACR for contributions to cancer research
The American Association for Cancer Research (AACR) has honored acclaimed investigator Karen Lu, M.D., chair of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, as one of the inaugural recipients of the Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR.
“We are thrilled to see Karen recognized by AACR for her enduring...
MD Anderson applauds Houston City Council for amending smoking ordinance to include e-cigarettes
The University of Texas MD Anderson Cancer Center applauds the unanimous vote by Houston City Council today to amend the city’s ordinance...
Distinct classes of fibroblasts in tumors play opposing roles, promoting or restraining pancreatic cancer growth
Researchers at The University of Texas MD Anderson Cancer Center have discovered that two distinct classes of cancer-associated fibroblasts...
MD Anderson launches James P. Allison Institute to usher in new era for immunotherapy
The University of Texas MD Anderson Cancer Center today launched the James P. Allison Institute, a visionary research and innovation hub within MD Anderson designed to foster groundbreaking science, to develop new treatments and to bring the benefits of immunotherapy to all patients.
The Allison Institute will advance exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and...
Novel therapy could help people with asthma, COPD, cystic fibrosis and cancer-related lung disease
A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled...
Neal Copeland and Nancy Jenkins elected Fellows of the AACR Academy
Neal G. Copeland, Ph.D., and Nancy A. Jenkins, Ph.D., both professors of Genetics at The University of Texas MD Anderson Cancer Center...
MD Anderson Research Highlights: SGO 2022 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent studies in basic, translational and...
Computational approach enables spatial mapping of single-cell data within tissues
A new computational approach developed by researchers at The University of Texas MD Anderson Cancer Center successfully combines data from...
Axi-cel proves effective as first-line treatment for high-risk lymphoma
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with...
MD Anderson Research Highlights for March 9, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
Study defines stem cell groups that drive myelodysplastic syndromes, finds potential targeted therapy option
Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes...